Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Tislelizumab can cause cutaneous lupus erythematosus.

A woman with lupus had unusual symptoms like blisters, skin inflammation, and throat ulcers, which improved with steroid and dapsone treatment.

A woman with lupus developed a rare skin condition, which improved with increased medication.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Early scar classification in lupus can improve treatment and patient outcomes.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

Early and accurate diagnosis is crucial for effectively managing hair loss in lupus and alopecia areata.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.

Skin symptoms are common in lupus patients in Antananarivo.

Skin symptoms in lupus help diagnose and manage the disease early.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

A rare lupus case on the chin was successfully treated with steroids and immunomodulators after accurate diagnosis using advanced imaging techniques.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Many Iraqi patients had skin problems at the site where a vein was taken for heart surgery.

Tumid lupus erythematosus can cause non-scarring hair loss on the scalp and requires careful diagnosis.

The patient with lupus and Degos' disease showed significant improvement with treatment.

A woman developed skin lesions after PRP injections, possibly linked to COVID-19 infection and vaccination.

Two patients with lupus had an unusual type of hair loss not typical for the disease.

The child was diagnosed with cutaneous leishmaniasis.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.